Antibodies News and Research

RSS

WHO says worst is yet to come as COVID-19 pandemic speeds up

The true number of global infections and deaths, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is likely to be significantly higher due to lack of testing. Some people are also asymptomatic, which means they had no symptoms of the illness.

29 Jun 2020

A glycan analysis of SARS-CoV-2 ACE2 complex

Researchers in the U.S. have produced molecular dynamic simulations of the Spike protein found on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its interaction with the host cell receptor angiotensin-converting enzyme 2 (ACE2).

29 Jun 2020

Sanford Burnham Prebys announces research agreement with Lilly to identify COVID-19 antibodies

Sanford Burnham Prebys Medical Discovery Institute today announced a research agreement with Eli Lilly and Company (Lilly) to characterize Lilly's next-generation anti-SARS-CoV-2 antibodies.

29 Jun 2020

Live attenuated vaccines may prevent lung inflammation and sepsis associated with COVID-19

A paper published by Paul Fidel, Jr., PhD, Professor and Director of the Center of Excellence in Oral and Craniofacial Biology and Associate Dean for Research at LSU Health New Orleans School of Dentistry, and Mairi Noverr, PhD, Professor of Microbiology & Immunology at Tulane University School of Medicine in New Orleans, suggests that live attenuated vaccines such as MMR (measles, mumps and rubella) may prevent the severe lung inflammation and sepsis associated with COVID-19 infection.

26 Jun 2020

Brazilian startup to develop a low-cost high-performance COVID-19 diagnostic test

Researchers at Biolinker, a biotech startup based in São Paulo, Brazil, are developing a low-cost high-performance COVID-19 diagnostic test using only locally sourced inputs.

26 Jun 2020

New Ebola strain may emerge in the Democratic Republic of Congo, say scientists

Scientists fear a new Ebola strain might emerge in the Democratic Republic of Congo if two versions of the disease mix together to form a new, potentially deadlier version.

26 Jun 2020

Timing of antibody testing is critical for accurate COVID-19 detection

Scientists have analysed data from around the world to examine the accuracy of antibody tests for COVID-19, and have shown that the timing of testing is critical. The tests do not work accurately when administered at the wrong time.

26 Jun 2020

BATM provides business and trading update

BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, provides the following business and trading update.

26 Jun 2020

GlobalData: Uncertainty during COVID-19 increases demand for immunity-boosting products

Ongoing research around protective immunity against COVID-19 has not yet helped to define ways of how the public can protect themselves from the illness, minimize the symptoms, and avoid re-infection.

26 Jun 2020

IQWiG supports initial assessment of coronavirus diagnostics

As a founding member, the Institute for Quality and Efficiency in Health Care (IQWiG) has been involved in EUnetHTA, a European network for Health Technology Assessment (HTA), since 2006.

26 Jun 2020

Antibody tests may give false hope of immunity, health experts warn

Amid the coronavirus pandemic, health experts warn against the use of antibody tests to determine if a person has immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An antibody test determines if a person developed antibodies against the infection due to past exposure.

26 Jun 2020

China to initiate phase 3 SARS-CoV-2 vaccine trial in UAE

Now, China is ready to run its large-scale phase III clinical trial of its novel coronavirus candidate in the United Arab Emirates (UAE). Over a dozen experimental vaccines are being trialed across the globe, but China’s vaccine is the first one to proceed to phase III human trials.

26 Jun 2020

Chilblains and COVID-19

The current COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is primarily a respiratory infection, though the majority of cases are asymptomatic or mild disease. However, other manifestations are also being reported, such as gastrointestinal features, neurological signs, and skin symptoms. A new study published online in the journal JAMA Dermatology in June 2020 examines the possibility that chilblains could be a manifestation of COVID-19.

26 Jun 2020

Entos Pharmaceuticals selects two lead DNA vaccine candidates for COVID-19

Entos Pharmaceuticals, a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform, today announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA vaccine from its prototyping program launched at the onset of the global COVID-19 pandemic.

25 Jun 2020

Researchers develop unique saliva-based test for COVID-19 detection

University of Saskatchewan researchers are part of two COVID-19-related projects awarded major federal funding today--one to develop a unique saliva-based test for COVID-19 detection and the other to track COVID-19 incidence rates among Canadian dentists.

25 Jun 2020

Study identifies new allergy pathway

Researchers at Johns Hopkins Bloomberg School of Public Health have identified the sequence of molecular events by which tiny, tick-like creatures called house dust mites trigger asthma and allergic rhinitis.

25 Jun 2020

USask researchers receive $900,000 to help strengthen Canada's rapid response to COVID-19

The Canadian Institutes of Health Research has awarded three University of Saskatchewan research teams a total of $900,000 to help strengthen Canada's rapid response to the COVID-19 pandemic which had killed more than 450,000 people worldwide.

25 Jun 2020

Emory launches COVIDVu study to understand the extent of epidemic across the U.S.

Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.

25 Jun 2020

New Cochrane review assesses the accuracy of COVID-19 antibody tests

Today Cochrane, a global independent organization that reviews evidence from research to inform health decision-making, publishes a review of studies looking at the accuracy of COVID-19 antibody tests.

25 Jun 2020

Superbug hijacks the wound healing system to cause serious and persistent disease

Monash University researchers have discovered that the devastating bacterial superbug Clostridioides difficile hijacks the human wound healing system in order to cause serious and persistent disease, opening up the development of new therapies to treat the disease.

25 Jun 2020

Antibodies News and Research

WHO says worst is yet to come as COVID-19 pandemic speeds up

A glycan analysis of SARS-CoV-2 ACE2 complex

Sanford Burnham Prebys announces research agreement with Lilly to identify COVID-19 antibodies

Live attenuated vaccines may prevent lung inflammation and sepsis associated with COVID-19

Brazilian startup to develop a low-cost high-performance COVID-19 diagnostic test

New Ebola strain may emerge in the Democratic Republic of Congo, say scientists

Timing of antibody testing is critical for accurate COVID-19 detection

BATM provides business and trading update

GlobalData: Uncertainty during COVID-19 increases demand for immunity-boosting products

IQWiG supports initial assessment of coronavirus diagnostics

Antibody tests may give false hope of immunity, health experts warn

China to initiate phase 3 SARS-CoV-2 vaccine trial in UAE

Chilblains and COVID-19

Entos Pharmaceuticals selects two lead DNA vaccine candidates for COVID-19

Researchers develop unique saliva-based test for COVID-19 detection

Study identifies new allergy pathway

USask researchers receive $900,000 to help strengthen Canada's rapid response to COVID-19

Emory launches COVIDVu study to understand the extent of epidemic across the U.S.

New Cochrane review assesses the accuracy of COVID-19 antibody tests

Superbug hijacks the wound healing system to cause serious and persistent disease

Immunology eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News